# Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population

> **NCT02565784** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 100 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DEVICE:** Restylane
- **DEVICE:** Perlane

## Key facts

- **NCT ID:** NCT02565784
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-12-29
- **Final completion:** 2018-09-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565784, "Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02565784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*